Acute activation of LevRs initiates MEF-2-dependent changes in transcription and a retrograde change in YFP::RAB-3. After 1 hour, Levamisole (200µM) and mock treated animals were subjected to RNA extraction or imaging. A) Expression of frm-4 was measured by qPCR (n=6 for Wild type and mef-2; n=3 for unc-29). Values that differ significantly from controls are indicated: (#) p<0.05, (*) p<0.01, Mann-Whitney. B–I) YFP::RAB-3 in the DA neurons is shown for the indicated genotypes. Scale bars indicate 10 µm. J) Average RAB-3 punctal fluorescence was compared in wild-type (n=25 mock, n=18 lev.), unc-29(x29) (n=16 mock, n=18 lev.), mef-2(gv1) (n=20 mock, n=16 lev.), and mef-2 muscle rescue (n=12 mock, n=17 lev.). (K–O) unc-29 mutations suppress the accumulation of YFP::RAB-3 in mir-1 mutants. YFP::RAB-3 punctal fluorescence is shown in the indicated genotypes. O) Average RAB-3 punctal fluorescence was compared in wild-type, unc-29(x29), mir-1(gk276) and mir-1 unc-29 double mutants [n=30 WT. n=26 mir-1, n=31 unc-29, n=35 mir-1 unc-29]. Values that differ significantly from wild-type controls are indicated: (**) p<0.001, Student’s t-test. (P - Q) Nicotine treatment did not alter RAB-3 fluorescence in WT. Q) RAB-3 punctal fluorescence was compared in nicotine treated and control animals [n=33 mock, n=33 nic.]. R) A model for miR-1 regulation of the MEF-2 dependent retrograde signal. miR-1 regulates muscle sensitivity to ACh by regulating the LevR and the magnitude of pre-synaptic release by regulating the activity of MEF-2. We suggest that mis-regulation of MEF-2 either initiates or modulates a retrograde signal that inhibits ACh release, most likely by decreasing the activity of RAB-3. Our data are consistent with miR-1/UNC-29/MEF-2 acting as part of a nicotinic signal transduction pathway to couple muscle activity to the generation of a retrograde signal that inhibits neurotransmitter release.